<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03531463</url>
  </required_header>
  <id_info>
    <org_study_id>2018/476-D</org_study_id>
    <nct_id>NCT03531463</nct_id>
  </id_info>
  <brief_title>The Nordic DeltaCon Trial for Displaced Proximal Humeral Fractures in Elderly</brief_title>
  <acronym>DeltaCon</acronym>
  <official_title>Nordic DeltaCon Trial: Non-operative Treatment Versus Reversed Total Shoulder Prosthesis in Patients Sixty Five Years of Age and Older With Displaced 3- and 4 Parts Proximal Humeral Fractures - a Prospective, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Nordic DeltaCon Trial is a prospective, single-blinded, randomized, controlled,
      multi-center and multi-national trial comparing reverse prosthesis and non-operative
      treatment in displaced proximal humerus fractures, in the elderly patients aged 65 to 85
      years with displaced OTA/AO group B2 or C2 fractures (According to the new 2018 revision:
      AO/OTA (Orthopaedic Trauma Association) group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. )
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single-blinded, multi-center, multi-national (Finland, Sweden, Denmark, Norway) Primary
      outcome in this study is QuickDASH (The short form of Disabilities of the arm, shoulder and
      hand) score measured at two years.

      Secondary outcomes are QuickDASH at/after one, two (short term) and five years (medium term),
      general visual analog scale (VAS) for pain, Oxford shoulder score (OSS), Constant-score (CS),
      number of re-operations and complications. Quality of life is assessed with 15-D.
      Cost-effectiveness analysis will be performed after completion of the trial.

      In addition to 2 years main outcome (short term) follow-up will continue to 5 years (medium
      term) and 10 years (long term). The power calculation is based on 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled semiblinded trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Physiotheraphists specialized in shoulder injuries collect all data and perform all tests / interviews of patients during FU at 3 months, 1-2-5 years. Blinded for the allocation / treatment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Quick-DASH</measure>
    <time_frame>2 years</time_frame>
    <description>The short form of Disabilities of the arm, shoulder and hand</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxford Shoulder Score</measure>
    <time_frame>2 years</time_frame>
    <description>Shoulder specific patient self-assesment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>15 D Quality of Life</measure>
    <time_frame>2 years</time_frame>
    <description>15 Questions 5 levels Generic Score (Harri Sintonen)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constant score</measure>
    <time_frame>2 years</time_frame>
    <description>Functional outcome for the shoulder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS pain</measure>
    <time_frame>2 years</time_frame>
    <description>General visual analog scale (VAS) for pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic + CT</measure>
    <time_frame>2 years</time_frame>
    <description>Plain radiographs and CT of injured shoulder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient involvement</measure>
    <time_frame>2 years</time_frame>
    <description>The aim of the interviews will be to move towards patient-centered medicine by taking into account the goals, preferences and values of patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Proximal Humeral Fracture</condition>
  <arm_group>
    <arm_group_label>Operative treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Operative treatment of the displaced proximal humeral fracture with a reversed total shoulder prothesis (Delta prosthesis) using a stadardized deltopectoral approach, bone block grafting and thread cerclages of the tubercles.
Rehabilitation with standardized physiotherapy guideline and self exercise protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Operative treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Rehabilitation with standardized physiotherapy guideline and self exercise protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Operative treatment with Reversed Total Shoulder Prosthesis</intervention_name>
    <description>The standardized approach is the delto-pectoral to minimize any damage of the deltoid muscle. A cemented monoblock humeral stem will be implanted. Braided polyester suture-cerclages engaging the insertion of the subscapular and infraspinatus tendons enforced by a bonegraft or a &quot;horseshoe-graft&quot; from the humeral head will be used</description>
    <arm_group_label>Operative treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Low energy AO/OTA group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. Both B and C type includes
        subgroups: Displaced [2], Impacted [3] or Non impacted [4] from the universal modifiers
        list.

        Exclusion Criteria:

        Radiographic Mal-inclination Less than; varus 30°or valgus 45° Less than 50% contact
        between head fragment and meta-/diaphysis Head split fractures with more than 10% of the
        articular surface in the main head fragment.

        Head split fractures (group 11-C3.2 and 11-C3.3) with more than 10% of the articular
        surface in the main head fragment.

        Dislocation or fracture-dislocation of the gleno-humeral joint Pathological fracture

        General

          -  Refuse to participate

          -  Age under 65 years of age, or over 85 years of age

          -  Serious poly-trauma or additional surgery

          -  Non-independent, drug/alcohol abuse or institutionalized (low co-operation)

          -  Contra-indications for surgery

          -  Does not understand written and spoken guidance in local languages

          -  Previous fracture with symptomatic sequelae in either shoulder

          -  Patients living outside the hospital's catchment area
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ville Mattila, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Professor in orthopedics and traumatology, Tampere University Chief of musculoskeletal department, Tampere University Hospital Visiting professor, Karolinska Institute, Stockholm</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antti Launonen, MD, PhD</last_name>
    <phone>00358405508210</phone>
    <email>antti.launonen@pshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tore Fjalestad, MD, PhD</last_name>
    <phone>004797013389</phone>
    <email>torfja@online.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampere University Hospital, Division of Orthopaedics</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antti Launonen, MD, PhD</last_name>
      <email>antti.launonen@pshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tore Fjalestad, MD, PhD</last_name>
      <phone>0047 22118080</phone>
      <email>tofjal@ous-hf.no</email>
    </contact>
    <investigator>
      <last_name>Tore Fjalestad, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>https://oslo-universitetssykehus.no/avdelinger/ortopedisk-klinikk/ortopedisk-avdeling-ulleval/brudd-i-ovre-del-av-overarmsbeinet-proksimale-humerus-den-nordiske-deltacon-studien</url>
    <description>Trial website for patients, their relatives and health workers</description>
  </link>
  <reference>
    <citation>Launonen AP, Fjalestad T, Laitinen MK, Lähdeoja T, Ekholm C, Wagle T, Mattila VM; NITEP-group. Nordic Innovative Trials to Evaluate osteoPorotic Fractures (NITEP) Collaboration: The Nordic DeltaCon Trial protocol-non-operative treatment versus reversed total shoulder arthroplasty in patients 65 years of age and older with a displaced proximal humerus fracture: a prospective, randomised controlled trial. BMJ Open. 2019 Jan 29;9(1):e024916. doi: 10.1136/bmjopen-2018-024916.</citation>
    <PMID>30700485</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>April 27, 2018</study_first_submitted>
  <study_first_submitted_qc>May 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2018</study_first_posted>
  <last_update_submitted>September 7, 2019</last_update_submitted>
  <last_update_submitted_qc>September 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Tore Fjalestad</investigator_full_name>
    <investigator_title>Principal investigator Tore Fjalestad, MD. Ph.D. Consultant Orthopaedic Surgeon, Mail: torfja@online.no / tofjal@ous-hf.no , Ph:+4797013389</investigator_title>
  </responsible_party>
  <keyword>Displaced</keyword>
  <keyword>Non-Operative treatment</keyword>
  <keyword>Reversed Total Shoulder Prosthesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Humeral Fractures</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

